Skip to main content

Stock Price Forecast

Aug. 22, 2025


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Celcuity Inc. chart...

About the Company

We do not have any company description for Celcuity Inc. at the moment.

Exchange

Nasdaq

$332M

Total Revenue

41

Employees

$2B

Market Capitalization

-4.47

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest News on Celcuity Inc.

Celcuity Inc. (NASDAQ:CELC) Q2 2025 Earnings Call Transcript

on MSN ago, source: Insider Monkey on MSN.com

Q2 2025 Earnings Call Transcript August 15, 2025 Operator: Good afternoon, ladies and gentlemen, and welcome to the Celcuity ...

Celcuity Inc. to Release First Quarter 2025 Financial Results ... - Nasdaq

3mon ago, source: Nasdaq

Celcuity Inc. announced that it will release its financial results for the first quarter of 2025 after the market closes on May 14, 2025, and will host a webcast and teleconference at 4:30 p.m ...

Celcuity Inc (CELC) Q2 2025 Earnings Call Highlights: Navigating Losses and Strategic Advances

8d ago, source: Yahoo Finance

Despite increased losses, Celcuity Inc (CELC) makes significant strides in clinical trials and secures funding for future growth.

Celcuity Inc. Schedules Release of Second Quarter 2025 Financial Results and Webcast/Conference Call

16d ago, source: Yahoo Finance

Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the second ...

Celcuity Inc. CEO Brian Sullivan to Speak at Upcoming Investor ...

5mon ago, source: Nasdaq

Celcuity Inc., a clinical-stage biotechnology company based in Minneapolis focused on targeted therapies for oncology, announced that CEO and Co-founder Brian Sullivan will present at upcoming ...

Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2024 ...

5mon ago, source: Seeking Alpha

To participate in the teleconference, domestic callers should dial 1-800-717-1738 and international callers should dial 1-646-307-1865. A live webcast presentation can also be accessed using this ...

Celcuity Inc. Schedules Release of Third Quarter 2024 ... - Morningstar

9mon ago, source: Morningstar

Contacts: Celcuity Inc. Brian Sullivan, bsullivan@celcuity.com Vicky Hahne, vhahne@celcuity.com (763) 392-0123 ICR Westwicke Maria Yonkoski, maria.yonkoski@westwicke.com (203) 682-7167 ...

Celcuity Inc. Schedules Release of First Quarter 2025 ... - Morningstar

3mon ago, source: Morningstar

Contacts: Celcuity Inc. Brian Sullivan, bsullivan@celcuity.com Vicky Hahne, vhahne@celcuity.com (763) 392-0123 ICR Healthcare Patti Bank, patti.bank@icrhealthcare.com (415) 513-1284 ...

Celcuity Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update

8d ago, source: FinanzNachrichten.de

Reported statistically significant and clinically meaningful improvement in both primary endpoints from the PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 trialHazard ratios and improvements in med ...

Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial ...

1y ago, source: Seeking Alpha

Contacts: Celcuity Inc. Brian Sullivan, bsullivan@celcuity.com Vicky Hahne, vhahne@celcuity.com (763) 392-0123 ICR Westwicke Maria Yonkoski, maria.yonkoski@westwicke.com (203) 682-7167 ...

Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial ...

1y ago, source: Business Insider

The Celcuity management team will host a webcast/conference call at 4:30 p.m. ET today to discuss the fourth quarter and full year 2023 financial results and provide a corporate update.

Similar Companies
Company Ticker 90 Days Forecast Market Cap. (USD M) P/E P/B
Aclarion, Inc. ACON Predict 2.93 -0.03 1.17
Aclarion, Inc. ACONW Predict 0.45 None 0.18
Advanced Biomed Inc. ADVB Predict 9.54 None 2.31
AMERICAN SHARED HOSPITAL SERVICES AMS Predict 16.38 5.20 0.66
BIODESIX INC BDSX Predict 58.05 -3.00 51.01
BioNexus Gene Lab Corp BGLC Predict 76.36 None 9.83
Burning Rock Biotech Ltd BNR Predict 0.00 None 0.00
Caris Life Sciences, Inc. CAI Predict 11046.86 7.55 24.39
CareDx, Inc. CDNA Predict 648.61 12.55 1.98
Celcuity Inc. CELC Predict 2272.92 -4.47 51.22
CASTLE BIOSCIENCES INC CSTL Predict 582.23 -2110.50 1.28
QUEST DIAGNOSTICS INC DGX Predict 20365.99 21.44 2.82
EXACT SCIENCES CORP EXAS Predict 8982.30 -343.62 3.64
Fulgent Genetics, Inc. FLGT Predict 649.52 516.76 0.58
Fortrea Holdings Inc. FTRE Predict 730.03 -6.75 1.24
Guardant Health, Inc. GH Predict 7642.94 -8.86 -22.95
GRAIL, Inc. GRAL Predict 1234.28 None 0.53
LABCORP HOLDINGS INC. LH Predict 23441.05 30.71 2.77
Natera, Inc. NTRA Predict 22646.96 -74.23 18.17
PSYCHEMEDICS CORP PMD Predict 11.79 -5.67 2.16
PSYCHEMEDICS CORP PMDI Predict 13.99 None 2.73
Personalis, Inc. PSNL Predict 407.79 -2.25 2.14
RadNet, Inc. RDNT Predict 6656.03 462.82 7.14
Renalytix plc RENXF Predict 9.96 None None
Renalytix plc RNLXY Predict 23.23 None None
SERA PROGNOSTICS, INC. SERA Predict 102.46 -8.99 1.16
VERACYTE, INC. VCYT Predict 2477.06 94.06 2.03
EXAGEN INC. XGN Predict 208.77 -5.36 9.93

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Investment Dashboard

Loading your portfolio...